Is Honey recalled?
37 FDA recalls mention Honey. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Honey.
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Class II · Moderate risk Ongoing
Reason CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Class I · High risk Ongoing
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing
Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Class I · High risk Ongoing
Reason Microbial Contamination of Non-Sterile Products
Class I · High risk Ongoing
Reason Microbial Contamination of Non-Sterile Products
Class II · Moderate risk Terminated
Reason CGMP Deviations: products were stored outside the drug label specifications.
Class II · Moderate risk Ongoing
Reason CGMP Deviations: product held outside appropriate storage temperature conditions.
Class II · Moderate risk Terminated
Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk Terminated
Reason cGMP deviations
Class II · Moderate risk Terminated
Reason cGMP deviations
Class II · Moderate risk Terminated
Reason cGMP deviations
Class II · Moderate risk Terminated
Reason cGMP deviations
Class II · Moderate risk Terminated
Reason cGMP deviations
Class III · Low risk Terminated
Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.